Skip to content

Innoviva, Inc. INVA Interest Expense

Interest Expense at other companies

Insmed logo
InsmedINSM
$20.08M-6.9%
Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND
$1.75M+101%
Alkermes logo
AlkermesALKS
$20.89M
Organon logo
OrganonOGN
$111M-10.5%
Royalty Pharma logo
Royalty PharmaRPRX
$93.72M+43.6%
Savara logo
SavaraSVRA

Other financials

Income statement

See full
Revenue$98.0M+10.6%
Gross profit$75.8M+3.4%
Operating income$38.2M-7.9%
Net income$186.6M+501%
EPS (diluted)$2.22+400%

Balance sheet

See full
Cash & equivalents$603.1M+89.0%
Total debt$269.4M-40.3%
Total equity$1.3B
Total assets$1.8B+46.4%

Cash flow

See full
Operating cash flow$35.3M-27.4%
CapEx$492.0K
Free cash flow$34.8M-28.4%

Valuation

See full
Market cap$1.74B+51.8%
Enterprise value$1.41B+9.7%
P/E3.5×
P/S4.2×+1.0×

Profitability

See full
Gross margin73.7%-9.9pp
Operating margin38.1%-11.2pp
Net margin119.9%+107pp
FCF margin54.1%+5.3pp

Returns & leverage

See full
Return on equity29.1%
Debt / equity0.2×
Current ratio21.1×+18.7×

Where this comes from

Reported directly by Innoviva, Inc. in its filing.

Tagged under the XBRL concept us-gaap:InterestExpense.

The official record: Innoviva, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Innoviva, Inc.'s interest expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Innoviva, Inc.'s interest expense?
Innoviva, Inc. (INVA) reported interest expense of $5.44M in Q1 2026.
How has Innoviva, Inc.'s interest expense changed year-over-year?
Innoviva, Inc.'s interest expense increased by 15.4% year-over-year, from $4.71M to $5.44M.
What is the long-term trend for Innoviva, Inc.'s interest expense?
Over 4 years (2021 to 2025), Innoviva, Inc.'s interest expense has grown at a -3.3% compound annual growth rate (CAGR), from $19.07M to $16.7M.
What does interest expense mean?
Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.